Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status
Top Cited Papers
- 30 April 2001
- journal article
- research article
- Published by Elsevier
- Vol. 34 (4) , 570-575
- https://doi.org/10.1016/s0168-8278(00)00053-2
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- AETIOPATHOGENESIS OF HEPATOCELLULAR CARCINOMAJournal of Gastroenterology and Hepatology, 1996
- Identification and Screening of 416 Patients with Chronic Hepatitis at High Risk to Develop Hepatocellular CancerAnnals of Surgery, 1995
- Prevalence of hepatocellular carcinoma in alpha-1-antitrypsin deficiencyJournal of Hepatology, 1994
- Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosisJournal of Hepatology, 1994
- Serum alpha‐fetoprotein and lens culinaris agglutinin‐reactive fraction of alpha‐fetoprotein in patients with hepatocellular carcinomaLiver International, 1993
- Hepatocellular Carcinoma in Liver Cirrhosis: A Prospective StudyScandinavian Journal of Gastroenterology, 1993
- Specificities of serum α-fetoprotein in HBsAg+ and HBsAg− patients in the diagnosis of hepatocellular carcinomaHepatology, 1991
- Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinomaThe Lancet, 1990
- Alpha‐fetoprotein changes in the course of chronic hepatitis: relation to bridging hepatic necrosis and hepatocellular carcinomaLiver International, 1986
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973